The low density lipoprotein receptor: structure, function and pharmacological modulationCATAPANO, A. L.Pharmacology & therapeutics (Oxford). 1989, Vol 43, Num 2, pp 187-219, issn 0163-7258Article

Ezetimibe : a selective inhibitor of cholesterol absorptionCATAPANO, A. L.European heart journal supplements. 2001, Vol 3, Num E, pp E6-E10, issn 1520-765XConference Paper

THERAPEUTIC SIGNIFICANCE OF HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC DRUGS.SIRTORI CR; CATAPANO A; PAOLETTI R et al.1977; ATHEROSCLER. REV.; U.S.A.; DA. 1977; VOL. 2; PP. 113-153; BIBL. 10 P. 1/2Article

Effects of insulin deficiency on the catabolism of plasma lipoproteins and on the expression of hepatic lipoprotein receptors in ratsTREZZI, E; CATAPANO, A. L.Pharmacological research communications. 1984, Vol 16, Num 6, pp 539-548, issn 0031-6989Article

METFORMIN: AN ANTIATHEROSCLEROTIC AGENT MODIFYING VERY LOW DENSITY LIPOPROTEINS IN RABBITS.SIRTORI CR; CATAPANO A; GHISELLI GC et al.1977; ATHEROSCLEROSIS; NETHERL.; DA. 1977; VOL. 26; NO 1; PP. 79-89; BIBL. 24 REF.Article

Antioxidant effect of flavonoidsCATAPANO, A. L.Angiology. 1997, Vol 48, Num 1, pp 39-44, issn 0003-3197Conference Paper

IN VIVO AND IN VITRO EFFECT OF SULFATED MUCOPOLYSACCHARIDE (3-GS) ON THE AORTIC UPTAKE OF A CHOLESTEROL-RICH VERY LOW DENSITY LIPOPROTEIN IN RABBITS.SIRTORI CR; CATAPANO A; GHISELLI G et al.1976; ARTERY; U.S.A.; DA. 1976; VOL. 2; NO 5; PP. 390-399; BIBL. 2 P.Article

Proceedings/Symposium on high-density lipoproteins: physiopathological aspects and clinical significance, Bellagio, ITA, September 1985CATAPANO, A. L; SALVIOLI, G; VERGANI, C et al.Atherosclerosis reviews. 1987, Vol 16, issn 0362-1650, XIII-216 pConference Proceedings

Static analysis of laminated beams via a unified formulationCATAPANO, A; GIUNTA, G; BELOUETTAR, S et al.Composite structures. 2011, Vol 94, Num 1, pp 75-83, issn 0263-8223, 9 p.Article

Experimental hypothyroidism modulates the expression of the low density lipoprotein receptor by the liverSCARABOTTOLO, L; TREZZI, E; ROMA, P et al.Atherosclerosis. 1986, Vol 59, Num 3, pp 329-333, issn 0021-9150Article

Nk-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, decreases apolipoprotein B-100 secretion from Hep G2 cellsOOYEN, C; ZECCA, A; BERSINO, A. M et al.Atherosclerosis. 1999, Vol 145, Num 1, pp 87-95, issn 0021-9150Article

Decreased intracellular degradation and increased secretion of apo B-100 in Hep G2 cells after inhibition of cholesteryl ester synthesisOOYEN, C; ZECCA, A; ZANELLI, T et al.Atherosclerosis. 1997, Vol 130, Num 1-2, pp 143-152, issn 0021-9150Article

Plasma lipids, lipoproteins and apoproteins B and A-I before and after a 24 h endurance race in cross-country skiersZULIANI, U; BONETTI, A; CERIOLI, G et al.Journal of sports medicine and physical fitness. 1986, Vol 26, Num 1, pp 8-10, issn 0022-4707Article

Failure Analysis of Composite Plates Subjected to Localized Loadings via a Unified FormulationGIUNTA, G; CATAPANO, A; BELOUETTAR, S et al.Journal of engineering mechanics. 2012, Vol 138, Num 5, pp 458-467, issn 0733-9399, 10 p.Article

HDL₃ induces cyclooxygenase-2 expression and prostacyclin release in human endothelial cells via a p38 MAPK/CRE-dependent pathway: Effects on COX-2/PGI-synthase couplingNORATA, G. D; CALLEGARI, E; INOUE, H et al.Arteriosclerosis, thrombosis, and vascular biology. 2004, Vol 24, Num 5, pp 871-877, issn 1079-5642, 7 p.Article

Changes in lipid metabolism induced by valley ball playingBONETTI, A; CATAPANO, A; NOVARINI, A et al.Journal of sports medicine and physical fitness. 1988, Vol 28, Num 1, pp 40-44, issn 0022-4707Article

Plasma resistin levels correlate with determinants of the metabolic syndromeNORATA, G. D; ONGARI, M; GARLASCHELLI, K et al.European journal of endocrinology. 2007, Vol 156, Num 2, pp 279-284, issn 0804-4643, 6 p.Article

Monoclonal antibody 5A binds apolipoprotein B-48 and inhibits the low density lipoprotein-receptor interactionCORSINI, A; FANTAPPIE, S; MARCOVINA, S et al.Biochemical and biophysical research communications (Print). 1989, Vol 162, Num 3, pp 908-915, issn 0006-291XArticle

Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferatingZHU, W; ROMA, P; PIRILLO, A et al.Arteriosclerosis, thrombosis, and vascular biology. 1996, Vol 16, Num 9, pp 1104-1111, issn 1079-5642Article

Cholesterol stimulation of HDL binding to human endothelial cells EAhy 926 and skin fibroblasts : evidence for a mechanism independent of cellular metabolismBERNINI, F; BELLOSTA, S; CORSINI, A et al.Biochimica et biophysica acta, L. Lipids and lipid metabolism. 1991, Vol 1083, Num 1, pp 94-100, issn 0005-2760, 7 p.Article

Oxidized LDL increase free cholesterol and fail to stimulate cholesterol esterification in murine macrophagesROMA, P; CATAPANO, A. L; BERTULLI, S. M et al.Biochemical and biophysical research communications (Print). 1990, Vol 171, Num 1, pp 123-131, issn 0006-291X, 9 p.Article

Effects of anabolic steroids, testosterone, and HGH on blood lipids and echocardiographic parameters in body buildersZULIANI, U; BERNARDINI, B; CATAPANO, A et al.International journal of sports medicine. 1989, Vol 10, Num 1, pp 62-66, issn 0172-4622, 5 p.Article

Progesterone modulates the expression of HDL binding sites in human skin fibroblastsCORSINI, A; GRANATA, A; BERNINI, F et al.Atherosclerosis. 1988, Vol 74, Num 1-2, pp 107-113, issn 0021-9150Article

Gene expression and intracellular pathways involved in endothelial dysfunction induced by VLDL and oxidised VLDLNORATA, G. D; PIRILLO, A; CALLEGARI, E et al.Cardiovascular research. 2003, Vol 59, Num 1, pp 169-180, issn 0008-6363, 12 p.Article

Immunoreactivity of apo B towards monoclonal antibodies that inhibit the LDL-receptor interaction : effects of LDL oxidationNEGRI, S; ROMA, P; FOGLIATTO, R et al.Atherosclerosis. 1993, Vol 101, Num 1, pp 37-41, issn 0021-9150Article